Sinyor M - Search Results

1

Does knowledge have a half-life? An observational study analyzing the use of older citations in medical and scientific publications.

Chow NLY, Tateishi N, Goldhar A, Zaheer R, Redelmeier DA, Cheung AH, Schaffer A, Sinyor M. Chow NLY, et al. Among authors: sinyor m. BMJ Open. 2023 May 22;13(5):e072374. doi: 10.1136/bmjopen-2023-072374. BMJ Open. 2023. PMID: 37217270 Free PMC article.

2

Is psychiatry ignoring suicide? The case for clozapine.

Sinyor M, Remington G. Sinyor M, et al. J Clin Psychopharmacol. 2012 Jun;32(3):307-8. doi: 10.1097/JCP.0b013e31825501fb. J Clin Psychopharmacol. 2012. PMID: 22544020 No abstract available.

3

Off-label use of atypical antipsychotics in personality disorders.

Rosenbluth M, Sinyor M. Rosenbluth M, et al. Among authors: sinyor m. Expert Opin Pharmacother. 2012 Aug;13(11):1575-85. doi: 10.1517/14656566.2011.608351. Epub 2011 Sep 20. Expert Opin Pharmacother. 2012. PMID: 21933032 Review.

4

Evolutionary approach highly informative but should not be overstated.

Sinyor M. Sinyor M. Can J Psychiatry. 2012 May;57(5):336; author reply 336-7. doi: 10.1177/070674371205700516. Can J Psychiatry. 2012. PMID: 23193554 No abstract available.

5

Suicide Risk and Prevention During the COVID-19 Pandemic: One Year On.

Sinyor M, Knipe D, Borges G, Ueda M, Pirkis J, Phillips MR, Gunnell D; International COVID-19 Suicide Prevention Research Collaboration. Sinyor M, et al. Arch Suicide Res. 2022 Oct-Dec;26(4):1944-1949. doi: 10.1080/13811118.2021.1955784. Epub 2021 Aug 23. Arch Suicide Res. 2022. PMID: 34425066

6

Suicide risk and prevention during the COVID-19 pandemic.

Gunnell D, Appleby L, Arensman E, Hawton K, John A, Kapur N, Khan M, O'Connor RC, Pirkis J; COVID-19 Suicide Prevention Research Collaboration. Gunnell D, et al. Lancet Psychiatry. 2020 Jun;7(6):468-471. doi: 10.1016/S2215-0366(20)30171-1. Epub 2020 Apr 21. Lancet Psychiatry. 2020. PMID: 32330430 Free PMC article. Review. No abstract available.

7

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctôt KL. Sinyor M, et al. J Clin Psychiatry. 2010 Mar;71(3):270-9. doi: 10.4088/JCP.08r04516blu. Epub 2010 Jan 26. J Clin Psychiatry. 2010. PMID: 20122371 Review.

8

The sequenced treatment alternatives to relieve depression (STAR*D) trial: a review.

Sinyor M, Schaffer A, Levitt A. Sinyor M, et al. Can J Psychiatry. 2010 Mar;55(3):126-35. doi: 10.1177/070674371005500303. Can J Psychiatry. 2010. PMID: 20370962 Review.

9

Substances used in completed suicide by overdose in Toronto: an observational study of coroner's data.

Sinyor M, Howlett A, Cheung AH, Schaffer A. Sinyor M, et al. Can J Psychiatry. 2012 Mar;57(3):184-91. doi: 10.1177/070674371205700308. Can J Psychiatry. 2012. PMID: 22398005

10

Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.

Sinyor M, Schaffer A, Smart KA, Levitt AJ, Lanctôt KL, Grysman NH. Sinyor M, et al. J Clin Psychiatry. 2012 Feb;73(2):e277-87. doi: 10.4088/JCP.11r07204. J Clin Psychiatry. 2012. PMID: 22401489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page